What Pfizer can learn in Tennessee when it comes to vaccine rollout
Tennessee’s diversity, size and urban-to-rural ratio are thought to be assets for drug-maker hoping to iron out vaccine distribution wrinkles. (Jim Weber/Daily Memphian)
Tennessee’s diversity, size and urban-to-rural ratio are thought to be assets for drug-maker hoping to iron out vaccine distribution wrinkles.
Topics
Clint Hermes Stacey Schultz-Cherry vaccine Pfizer
Jane Roberts
Longtime journalist Jane Roberts is a Minnesotan by birth and a Memphian by choice. She's lived and reported in the city more than two decades. She covers healthcare and higher education for The Daily Memphian.
Reading comments and joining the conversation are some of the many benefits of subscribing. Join the conversation by clicking the View Comments button below. Not a subscriber? Click here.
Our commenting policy can be viewed here.